✦ LIBER ✦

Urinary levels of urokinase-type plasminogen activator and its receptor in the detection of bladder carcinoma

✍ Scribed by Cornelis F. M. Sier; Francesco Blasi; Nicolai Sidenius

Publisher: John Wiley and Sons
Year: 2003
Tongue: English
Weight: 61 KB
Volume: 98
Category: Article
ISSN: 0008-543X
DOI: 10.1002/cncr.11751

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Urinary levels of urokinase-type plasmin

Urinary levels of urokinase-type plasminogen activator and its receptor in the detection of bladder carcinoma

✍ Roberto Casella; Shahrokh F. Shariat; Mara A. Monoski; Seth P. Lerner 📂 Article 📅 2002 🏛 John Wiley and Sons 🌐 English ⚖ 75 KB 👁 1 views

## Background: The authors found previously that plasma levels of urokinase-type plasminogen activator (upa) and its receptor (upar) were elevated in patients with bladder carcinoma and were associated with features of biologically aggressive disease. in the current study, they tested the hypothesi

Urokinase-type plasminogen activator, it

Urokinase-type plasminogen activator, its inhibitor, and its receptor in patients with upper urinary tract carcinoma

✍ Kuniaki Nakanishi; Toshiaki Kawai; Chikao Torikata; Takashi Aurues; Tomosumi Ike 📂 Article 📅 1998 🏛 John Wiley and Sons 🌐 English ⚖ 328 KB 👁 1 views

involved in tumor invasion and metastasis.

Expression and cellular localization of

Expression and cellular localization of the urokinase-type plasminogen activator and its receptor in human hepatocellular carcinoma

✍ Dubuisson, L.; Monvoisin, A.; Nielsen, B. S.; Le Bail, B.; Bioulac-Sage, P.; Ros 📂 Article 📅 2000 🏛 John Wiley and Sons 🌐 English ⚖ 437 KB 👁 1 views

The urokinase-type plasminogen activator (uPA) and its receptor (uPAR) play an important role in tumour invasion. Previous studies have shown by RT-PCR that uPA and uPAR mRNAs are expressed in human hepatocellular carcinoma (HCC). Here, in situ hybridization, immunohistochemistry, and double immuno¯

The content of urokinase-type plasminoge

The content of urokinase-type plasminogen activator antigen as a prognostic factor in urinary bladder cancer

✍ Yoshihiro Hasui; Kousuke Marutsuka; Junji Suzumiya; Shinichiro Kitada; Yukio Osa 📂 Article 📅 1992 🏛 John Wiley and Sons 🌐 French ⚖ 369 KB

## Urokinase -type plasminogen activator (u-PA) is thought to be implicated in cancer invasion and metastasis. The aim of this study was to determine whether the u-PA content of cancer tissue is a prognostic factor in bladder cancer. Tissue samples from 46 patients with bladder cancer were assesse

Low levels of urokinase plasminogen acti

Low levels of urokinase plasminogen activator components in basal cell carcinoma of the skin

✍ T. Maguire; D. Chin; D. Soutar; M.J. Duffy 📂 Article 📅 2000 🏛 John Wiley and Sons 🌐 French ⚖ 67 KB 👁 1 views

Basal cell carcinoma of the skin (BCC) is the most common cancer worldwide. Unlike most other human malignancies, BCCs rarely metastasise. In this investigation, we show that the serine protease urokinase plasminogen activator (u-PA), which is causally involved in metastasis, is expressed at lower l

Expression ofMet protein and urokinase-t

Expression ofMet protein and urokinase-type plasminogen activator receptor (uPA-R) in papillary carcinoma of the thyroid

✍ Zanetti, Antonio; Stoppacciaro, Antonella; Marzullo, Antonella; Ciabatta, Maria; 📂 Article 📅 1998 🏛 John Wiley and Sons 🌐 English ⚖ 314 KB 👁 1 views

Met protein encoded by MET oncogene is the high affinity receptor for hepatocyte growth factor (HGF)/scatter factor (SF). HGF/SF has to be cleaved in its heterodimeric form by the urokinase-type plasminogen activator (uPA) to become active as a ligand for Met receptor. The expression of Met protein